Summit Therapeutics reported cash from operations of -$141.12M and free cash flow of -$141.34M for the quarter ended Jun 2026, down 111.4% year over year. This cash flow statement covers 39 quarters of results from Apr 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Apr2017 | Jul2017 | Oct2017 | Jan2018 | Apr2018 | Jul2018 | Oct2018 | Jan2019 | Mar2019 | Jul2019 | Sep2019 | Oct2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||||
| Net Income | -19.60M | -27.10M | -22.16M | -12.69M | -16.94M | -20.30M | -536.19M | -15.79M | -20.49M | -36.21M | -45.51M | -62.72M | -60.83M | -65.62M | |||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 5.62M | 4.00M | 2.50M | 2.76M | 2.66M | 2.77M | 4.25M | 0.70M | 8.75M | 9.51M | 11.09M | 19.37M | 11.02M | 11.10M | 478.78M | 130.76M | 111.78M | 72.79M | 68.71M | ||||||||||||||||||||
| Deferred Taxes | |||||||||||||||||||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | |||||||||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 8.47M | 0.47M | |||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -23.57M | -9.18M | -19.00M | -19.22M | -8.55M | 5.19M | -13.13M | -29.27M | -14.90M | -19.46M | -30.13M | -33.00M | -30.30M | -48.67M | -61.17M | -66.74M | -93.08M | -101.94M | -122.29M | -141.12M | |||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.29M | 0.34M | 0.30M | 0.26M | 0.40M | -0.96M | 2.90M | -1.19M | 0.21M | 0.40M | 1.60M | 2.92M | -2.35M | 2.97M | 1.02M | 3.02M | 4.22M | 2.97M | |||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 1.37M | -0.93M | -0.46M | -0.70M | -1.23M | 1.41M | -0.35M | -0.01M | -0.00M | ||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -1.02M | -1.36M | 2.76M | -3.48M | -1.04M | -2.37M | 0.31M | 0.30M | 2.33M | -0.67M | 3.70M | -3.04M | -0.18M | 1.53M | 0.36M | 17.93M | -0.84M | -2.15M | 6.80M | -3.91M | |||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.42M | 1.76M | -3.52M | 0.44M | 7.90M | -0.04M | -3.24M | -4.29M | -0.20M | 5.35M | -2.23M | 5.93M | 5.89M | 2.28M | -7.59M | 14.04M | 0.94M | 5.53M | 12.22M | 20.74M | |||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 0.22M | 0.52M | -2.66M | -1.47M | -3.42M | 0.28M | |||||||||||||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | -0.00M | 0.12M | 0.36M | 0.29M | -0.02M | -0.01M | 0.05M | 0.02M | 0.05M | 0.00M | -2.45M | 0.00M | -0.01M | 2.60M | 1.42M | 2.25M | 0.86M | -3.87M | 1.03M | 0.22M | |||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 38.17M | 109.42M | 60.57M | 112.86M | 70.00M | 74.00M | 232.98M | 160.53M | 150.81M | 177.29M | 448.80M | ||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 0.00M | -0.12M | -0.36M | -0.29M | 0.02M | 0.01M | -645.06M | 0.21M | -3.49M | 60.57M | 19.87M | -200.08M | -108.61M | 83.48M | 160.11M | 150.81M | -0.07M | -485.16M | -0.24M | 222.90M | |||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.73M | 1.22M | 0.19M | 0.11M | 0.10M | 0.65M | 0.23M | 4.12M | 0.48M | 199.51M | 234.96M | -0.10M | 5.66M | 1.66M | 492.72M | 3.80M | 3.67M | ||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.68M | 1.26M | 25.19M | 75.00M | 520.06M | 80.11M | -0.08M | 0.23M | 6.25M | 0.48M | 200.21M | 204.14M | -23.61M | 7.68M | 2.22M | 33.81M | 573.82M | 3.80M | 231.08M | ||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 100.00M | 104.69M | 43.04M | -0.00M | 31.76M | 468.27M | |||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.25M | -0.42M | -0.17M | -0.60M | -1.83M | 1.38M | 0.44M | 0.29M | -0.17M | 0.27M | -0.04M | 0.01M | 0.11M | -0.11M | 0.04M | 0.06M | 0.02M | -0.02M | -0.02M | 0.00M | |||||||||||||||||||
| Change in Cash | -23.14M | -8.46M | 5.66M | -20.11M | 64.64M | 526.64M | -577.64M | -28.85M | -18.32M | 47.63M | -9.81M | -32.86M | 65.34M | 11.09M | 106.66M | 86.35M | -59.32M | -13.29M | -118.75M | 312.85M | |||||||||||||||||||
| Free Cash FlowFCF | -23.56M | -9.30M | -19.36M | -19.51M | -8.54M | 5.20M | -13.18M | -29.29M | -14.95M | -19.46M | -27.69M | -33.01M | -30.28M | -51.27M | -62.59M | -69.00M | -93.94M | -98.07M | -123.32M | -141.34M | |||||||||||||||||||
| Net Cash FlowNCF | -22.89M | -8.04M | 5.83M | -19.51M | 66.46M | 525.26M | -578.08M | -29.15M | -18.15M | 47.36M | -9.78M | -32.87M | 65.23M | 11.20M | 106.62M | 86.29M | -59.34M | -13.27M | -118.73M | 312.85M |